Global Contract Manufacturing Organization Service Market Outlook, Growth, Industry Trends 2022-2030

The Global Contract Manufacturing Organization Service Market expected to grow at a significant CAGR during the forecast period. This can be attributed to the growing need to reduce manufacturing cost, growing demand for high-quality bulk manufacturing, generic drugs, high cost of operations, and lack of in-house manufacturing capacity. With the growing requirement for generic medicines and biologics, the global industry has become more of a capital-intensive nature with complex manufacturing infrastructures, and many pharmaceutical companies have identified the potential profitability in contracting with a contract manufacturing outsourcing for both clinical and commercial stage manufacturing.

The contract manufacturing organization service industry is projected to witness significant growth in the mid- to long term, driven by a rapidly growing population and growing innovations in regions like North America, Europe, Asia Pacific, South America and the middle east. In addition, government initiatives towards increasing the number of pharmaceutical manufacturing facilities are also driving market growth in the region.

Market Trends in CONTRACT MANUFACTURING ORGANIZATION SERVICE

Global CONTRACT MANUFACTURING ORGANIZATION SERVICE market by Virtual molecules segment is expected to grow at a CAGR of 8.7% during the forecast period (2019–2024).

Intended Audience

Suppliers / Potential Investors

Traders, Distributors

Wholesalers

Importers and Exporters

Association

Government bodies

Segmental Insights

The global CONTRACT MANUFACTURING ORGANIZATION SERVICE market is segmented by types and product.

On the basis of the types, the market is segmented into Big Bio, Small and Medium Molecule, and Virtual/ Emerging type. Small and Medium Molecules segment of the global CONTRACT MANUFACTURING ORGANIZATION SERVICE market is expected to hold the largest market share during the forecast period.

On the basis of the product, the market is segmented into Oral Products, Injectable Products, Spays Products, and Others. The Oral Products segment is expected to grow at a high CAGR during the forecast period as they are a dominant mode of delivery, cost-effective, and more convenient to use for patients as compared to injections and sprays. Apart from being cost-effective, oral products provide increased physical and chemical stability and controlled-release options.

Get Your FREE Sample Copy of the CONTRACT MANUFACTURING ORGANIZATION SERVICE

Regional Analysis

Geographically, the global CONTRACT MANUFACTURING ORGANIZATION SERVICE market is segmented into North America, Europe, Asia Pacific, and the South America and the Middle East & Africa (SAMEA).

North American CONTRACT MANUFACTURING ORGANIZATION SERVICE market is expected to grow significantly during the forecast period as region has been at the forefront in terms of technology offerings as well as value-added services. The U.S. is the world’s largest market for drugs, accounting for more than half the R&D spending in biotechnology and pharmaceutical markets. Therefore, contract manufacturing organization plays an important role and significant investments have been made in new facilities and technologies to cater to a wide range of outsourcers.

Europe is a prominent region the global CONTRACT MANUFACTURING ORGANIZATION SERVICE market due to consistent growth and technological developments in the business model and many countries, in particular Germany and Italy, have attracted significant interest from international investors. Many European CMOs benefit from regulations regarding the import of products from outside Europe and promote the favourable treatment of products made locally.

Asia Pacific is expected to grow at the fastest pace owing to the fact that many multinational pharmaceutical companies have a strong interest in gaining access to the APAC region and are thus engaged in developing building infrastructure. The strengthening of government control of generic drugs, such as development of generic consistency evaluation, clinical trial data of audits and inspections, and improvement of Chinese drug firms’ R&D strength are further driving the growth of the market.

South America’s CONTRACT MANUFACTURING ORGANIZATION SERVICE market is expected to witness a significant growth during the forecast period. Low drug registration cost and continuous economic growth are among the key factors responsible for the growth of the CMO industry in South America.

Key Players

Key players in the Global Contract Manufacturing Organization Service Market include NIPRO PHARMA CORPORATION, Daito Pharmaceutical Co., Ltd., Teva Pharmaceutical Industries Ltd, Xinhua Pharm, Esteve Química, Zhejiang Huahai Pharmaceuticals Co., Ltd. (Huahai US Inc.), Catalent, Inc, Patheon (Thermo Fisher Scientific Inc.), Bio Pharma Solutions (Baxter Healthcare Corporation), and AbbVie Inc. among others.

CONTRACT MANUFACTURING ORGANIZATION SERVICE Market Segmentation

Types

Big Bio

Small and Medium Molecule

Virtual/ Emerging type

Product

Oral Products

Injectable Products

Spays Products

Others

By Geography

North America

Europe

Asia-Pacific

SAMEA

Why buy this report?

In our report, we have covered the latest market related technological trends, factors impacting the development, and competencies and capacities of the key companies in terms of production as well as sustainability and prospects. Moreover, following sections are specifically covered in the report.

Definitive Market Data

CONTRACT MANUFACTURING ORGANIZATION SERVICE Analysis

Competitive Analysis

Recent Opportunities in the Market

6-7-year performance forecasts: major segments covering types and product, and geographies

Market Share Analysis

Technology Assessment

Potential Venture Avenues